Cost-effectiveness analysis of newborn screening for sickle-cell disease in Spain-Reference-Cited by-同舟云学术

Cost-effectiveness analysis of newborn screening for sickle-cell disease in Spain

Published:2016-04-28 Issue:6 Volume:4 Page:567-575
ISSN:2167-8707
Container-title:Expert Opinion on Orphan Drugs
language:en
Short-container-title:Expert Opinion on Orphan Drugs

Author:

Castilla-Rodríguez Iván¹²,Cela Elena³,Vallejo-Torres Laura²⁴,Valcárcel-Nazco Cristina²⁴⁵,Dulín Elena⁶,Espada Mercedes⁷,Rausell Dolores⁸,Mar Javier⁴⁹,Serrano-Aguilar Pedro²⁴¹⁰

Affiliation:

1. Departamento de Ingeniería Informática y de Sistemas, Universidad de La Laguna, La Laguna, Spain

2. Centre for Biomedical Research of the Canary Islands (CIBICAN), S/C de Tenerife, Spain

3. Pediatric Hematology Unit, Hospital General Universitario Gregorio Marañón, Madrid, Spain

4. Health Services Research on Chronic Patients Network (REDISSEC), Spain

5. Canary Islands Foundation for Health Research (FUNCANIS), S/C de Tenerife, Spain

6. Newborn Screening Laboratory, Hospital General Universitario Gregorio Marañón, Madrid, Spain

7. Public Health Laboratory, Basque Government, Spain

8. Clinical Pathology Laboratory, Metabolic Disorders Unit, Hospital Universitario La Fe, Valencia, Spain

9. Clinical Management Service, Alto Deba Hospital, Mondragón, Spain

10. HTA Unit of the Canary Islands Health Service (SESCS), S/C de Tenerife, Spain

Funder

Seventh Framework Programme

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Link

https://www.tandfonline.com/doi/pdf/10.1080/21678707.2016.1179572

Reference50 articles.

1. Screening for sickle cell disease and thalassaemia: a systematic review with supplementary research.

2. Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease [see comments]

3. Survival estimates for patients with homozygous sickle-cell disease in Jamaica: a clinic-based population study

4. Malaria and the Red Cell

5. Epidemiology of haemoglobin disorders in Europe: an overview

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benefits and harms of antenatal and newborn screening programmes in health economic assessments: the VALENTIA systematic review and qualitative investigation;HEALTH TECHNOL ASSES;2024

2. Automated Generation of Discrete Event Simulation Models for the Economic Assessment of Interventions for Rare Diseases Using the RaDiOS Ontology;International Journal on Artificial Intelligence Tools;2023-02

3. Development of a conceptual model for evaluating new non-curative and curative therapies for sickle cell disease;PLOS ONE;2022-04-28

4. The Use of Cost-Effectiveness Analysis in Sickle Cell Disease: A Critical Review of the Literature;PharmacoEconomics;2021-08-09

5. The Methodological Quality and Challenges in Conducting Economic Evaluations of Newborn Screening: A Scoping Review;International Journal of Neonatal Screening;2020-11-23